ANTX
AN2 Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.89
−1.01%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.58x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- 1.18x
Liquidity & coverage
- Current ratio
- 14.32x
- Quick ratio
- 14.32x
- Cash ratio
- 14.04x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $74.4M
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- +0.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026